Piscataway, NJ, January 4, 2022–Camber Pharmaceuticals is pleased to announce the addition of the Amphetamine ER Capsules to their current portfolio.
Amphetamine ER Capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Amphetamine ER from Camber are available in 5, 10, 15, 20, 25, and 30 mg strengths. All strengths are available in 100 count bottles.
To find out more about Amphetamine ER Capsules please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
- Camber Pharmaceuticals Launches Generic Pepcid®
- Camber Pharmaceuticals Launches Generic Wellbutrin SR®
- Camber Pharmaceuticals Launches Generic Inspra®
- Camber Pharmaceuticals Launches Generic Prezista®
- Camber Pharmaceuticals Launches Generic Neurontin Caps®
- Camber Pharmaceuticals Launches Generic Zyprexa®